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Edited by Laszlo NagyAbstract To explore a novel adipokine, we screened adipocyte
diﬀerentiation-related gene and found that TIG2/chemerin was
strongly induced during the adipocyte diﬀerentiation. Chemerin
was secreted by the mature 3T3-L1 adipocytes and expressed
abundantly in adipose tissue in vivo as recently described.
Intriguingly, the expression of chemerin was diﬀerently regulated
in the liver and adipose tissue in db/db mice. In addition, serum
chemerin concentration was decreased in db/db mice. Chemerin
and its receptor/ChemR23 were expressed in mature adipocytes,
suggesting its function in autocrine/paracrine fashion. Finally,
chemerin potentiated insulin-stimulated glucose uptake concom-
itant with enhanced insulin signaling in the 3T3-L1 adipocytes.
These data establish that chemerin is a novel adipokine that reg-
ulates adipocyte function.
 2008 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Obesity is an emerging health hazard and contributes to the
increased morbidity and mortality particularly in Western
societies [1]. Obesity is frequently associated with the meta-
bolic syndrome that includes glucose intolerance, insulin resis-
tance, hypertension, hypertriglyceridemia, low HDL
cholesterol, and type2 diabetes (T2DM). Adipokines secreted
from adipose tissue play an essential role in these conditions
[2,3]. Adipocytes also secrete inﬂammatory cytokines which
are typically produced by macrophages, such as tumor necrosis
factor-a (TNF-a), interleukin-6 and the chemokine family
members, monocyte chemotactic protein-1 (MCP-1) that is
related to insulin resistance [4,5]. These adipokines exert their
eﬀect via endocrine, autocrine and paracrine fashion and
regulate metabolic status.*Corresponding author. Fax: +81 78 382 5899.
E-mail address: takahash@med.kobe-u.ac.jp (Y. Takahashi).
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doi:10.1016/j.febslet.2008.01.023The 3T3-L1 and 3T3-F422A culture lines, derived from
disaggregated Swiss 3T3 mouse embryos [6] are the most
widely used culture in vitro adipocyte models. Especially, the
3T3-L1 cell line is one of the most well-characterized and reli-
able models for studying the conversion of preadipocytes into
adipocytes. The expression of many adipokines is observed in
the process of diﬀerentiation. To elucidate molecular mecha-
nisms of obesity related disease such as diabetes and metabolic
syndrome, it is important to understand the function of these
adipokines. The 3T3-L1 adipocytes are very useful tool for
these purposes.
Chemerin, also known as tazarotene-induced gene 2 (TIG2)
[7], has been recently characterized as a chemotactic agent that
was identiﬁed as the ligand for an orphan G protein-coupled
receptor, ChemR23 expressed by immature dendritic cells
(DCs) and macrophages [8]. There have been several reports
that chemerin plays a potential role in controlling immune
responses at sites of inﬂammation or tissue injury as a chemo-
tactic factor for speciﬁc subsets of immunoregulatory antigen-
presenting cells [9,10]. However, it has not been elucidated the
role of chemerin in metabolic regulation.
More recently, it has been reported that chemerin is an
adipokine and regulates adipocyte diﬀerentiation [11], the
serum chemerin level was associated with body mass index, cir-
culating triglycerides, and blood pressure [12], and chemerin
stimulates ERK1/2 and lipolysis in the 3T3L1 adipocytes
[13]. Here we also identiﬁed TIG2/chemerin as a novel adipo-
kine. We further demonstrate that chemerin is an autocirne/
paracrine factor and stimulates insulin-dependent glucose
uptake concomitant with the enhanced insulin signaling in
adipocytes.2. Materials and methods
2.1. Materials
Mouse recombinant Chemerin and anti-human ChemR23 mono-
clonal antibody (MAB362) were purchased from R&D systems (Min-
neapolis, MN). Human insulin was obtained from Eli Lilly Japan
(Kobe, Japan). Dexamethasone and IBMX were purchased from
Sigma (St. Louis, MO). Anti IRS-1 and anti phosphotyrosine
(RC20H) antibody were purchased from Cell Signaling Technology
(Boston, MA) and BD Bioscience (San Jose, CA), respectively.blished by Elsevier B.V. All rights reserved.
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The 3T3-L1 cells and Cos7 cells were purchased from American
Type Culture Collection (Manassas, VA). The 3T3-L1 and 3T3-
F442A [14] preadipocytes were maintained and diﬀerentiated as previ-
ously described [14,15]. Diﬀerentiated adipocytes were used for the
experiments on the day 10 after the initiation of diﬀerentiation.2.3. Animals
Mouse experiments were performed according to the guidelines of
the animal ethics committee of Kobe University Graduate School of
Medicine. Male C57BL/6J mice and db/dbmice (10–12 weeks old) were
purchased from CLEA Japan (Osaka, Japan). The mice were kept on
12-h day/night cycle, were housed in cages and had free access to water
and normal chow.2.4. Diﬀerential display
To identify adipocyte diﬀerentiation-related gene, diﬀerential display
was conducted as described previously [16,17]. In brief, heat-denatured
total RNA (0.5 lg) from the 3T3-L1 adipocytes at the day 0 and 7 were
applied for reverse transcription, using the oligo (dT) primer T12MA,
T12MC, T12MG, or T12MT (M, a mixture of A, C, and G) as anchor
primer. PCR was performed using 1 lM anchor primer (T12MN), and
0.5 lM arbitrary. Radio-labeled PCR ampliﬁcation products were
analyzed by electrophoresis using denaturing 6% polyacrylamide gels.
The PCR fragments with diﬀerent densities were extracted and ream-
pliﬁed using the same primer set used for the diﬀerential display reac-
tions. The fragments were subcloned into a pGEM-T Easy vector
(Promega, MI) and sequencing analysis was performed.
2.5. Northern blot analysis and semiquantitative RT-PCR analysis
Total RNA was extracted from indicated tissues of 10-week-old
male C57BL/6J mice using TRIzol (Invitrogen, Carlsbad, CA). For
Northern blotting, total RNA (15 lg) was subjected and analyzed with
chemerin-speciﬁc probe (full length mouse TIG2 cDNA) as previously
described [18]. For semiquantitative PCR analysis, total RNA was
extracted from indicated tissues of 10-months-old male db/db mice.
First strand cDNA was synthesized from 1 lg of total RNA using
ThermoScript RT-PCR System (Invitrogen). The primers for mouse
36B4 were: 5 0-GAGGAATCAGATGAGGATATGGGA-3 0 and
5 0-AAGCAGGCTGACTTGGTTGC-30 and for mouse chemerin were
5 0-GTGCACAATCAAACCAAACG-30 and 5 0-GGCAAACTGTC-
CAGGTAGGA-3 0, respectively.
2.6. Cloning and in vitro expression of chemerin in Cos7 cells
We cloned mouse chemerin using cDNA from 3T3-L1 adipocytes as
a template. PCR was performed with following primers; m-chemerin-S;
5 0-CACCATGAAGTGCTTGCTGATCTCC-3 0 and m-chemerin-AS;
5 0-TTTGGTTCTCAGGGGCCCTGG-30. The control pcDNA3.1D/
V5-His-TOPO vector and the vector containing full-length chemerin
cDNA were transfected into Cos7 cell using Fugene (Boehringer
Mannheim) and the culture media was collected 48 h after transfection.
The media was immunoprecipitated using anti V5 antibody (Invitro-
gen) and immunoblot was performed using the same antibody.
2.7. Generation of recombinant human chemerin using baculovirus
Human chemerin cDNA was cloned using PCR from human
adipose tissue cDNA (Clontech, Mountain View, CA) into TOPO
TA cloning vector (Invitrogen). pFastBac1-Msp was constructed to
express a fusion protein with the N-terminal honey melittin signal
peptide as described [19]. The recombinant bacmid was transfected
into Sf9 cells using Cellfectin reagent (Life Technologies). Then, High
Five Cells (Invitrogen) were infected with the recombinant viruses.
After incubation for 3 days at 27 C, the supernatant was harvested.
After dialysis, the recombinant human chemerin was puriﬁed by
HiTrap SP XL and Tricorn Superdex 75 100/300 (Amersham Bio-
sciences, Piscataway, NJ). Purity of the protein was veriﬁed using
SDS–PAGE (Fig. 3A).
2.8. Preparation of antiserum
Human chemerin cDNA was subcloned into the pTE-14b vector
containing His tag. The expression vector was transformed into a
Competent AD494(DE3) Escherichia coli. After IPTG induction, thepelleted bacteria were washed, suspended in 20 mM Sodium phosphate
(pH 7.5), containing 500 mM NaCl, 0.1% TritonX-100 and 8 M urea,
and sonicated. The clear lysate was puriﬁed and eluted by imidazol
buﬀer using a HiTrap Chelating HP (Amersham Biosciences, Uppsala,
Sweden). The rabbit was immunized intracutaneously with 150 lg his-
tagged chemerin emulsiﬁed in Freunds complete adjuvant. Booster
doses of 300 lg his-tagged chemerin emulsiﬁed in FCA were adminis-
tered at 2 week intervals until the antibody titer was observed. The rab-
bit was bled 10 days after immunization. The speciﬁcity of the
antibody was veriﬁed by immunoblotting of recombinant human
chemerin (Fig. 3A) and absorption experiments (data not shown).
2.9. Glucose uptake in the 3T3-L1 adipocytes
The 3T3-L1 adipocytes were incubated with or without 100 n/ml
chemerin in Dulbeccos modiﬁed Eagles medium (DMEM) containing
10% FCS for 12 h before the glucose uptake assay. The assay was
essentially performed as described previously [17]. Brieﬂy, the cells
were washed several times with Hanks solution, and treated with
diﬀerent concentrations of insulin for 15 min at 37 C. Then 0.5 lCi
of [3H]-2-deoxy-D-glucose (NEN Life Science Products, Boston,
MA) was added to the medium containing 0.1 mM unlabeled
2-deoxy-D-glucose, and the cells were incubated further for 10 min.
The cells were then washed with phosphate-buﬀered saline, solubilized
with 0.2 M NaOH, and the radioactivity was counted using a liquid
scintillation counter. Data were representative of three experiments,
and each value was corrected for protein content.2.10. Immunoblot analysis and immunohitochemistry
Fifty ng of recombinant human chemerin was analyzed using anti-
human chemerin rabbit polyclonal antibody as primary antibody in
1:10000 dilution. As a second antibody, anti-rabbit IgG antibody
conjugated with HRP (Amersham) was used as previously described
[20]. To detect secreted endogenous chemerin in the 3T3-L1 culture
media, heat inactivated 10 ll of supernatant was applied for SDS–
PAGE and analyzed as described above. To examine IRb and IRS-1
tyrosine phosphorylation and detection of IRS-1-associated IRb,
immunoblot analysis was performed as previously described [21].
For immunohitochemistry, the 3T3-L1 adipocytes on coverslips were
permeabilized and blocked with the blocking solution (the MaxiTags
immunoperoxidase system; Themo Shandon, Pittsburgh, PA), and
incubated with the anti-human chemerin rabbit polyclonal antibody
or anti-human ChemR23 mouse monoclonal antibody was used as
the primary antibody in 1:100 dilutions, respectively. Biotinylated
anti-rabbit or mouse immunoglobulins (ENVISION kit; Dako,
Carpinteria, CA) were used as secondary antibodies. The avidin–
biotin-peroxidase complex method was used, and the samples were
developed with DAB as chromogen (Dako), counterstained with
hematoxylin as previously described [22,23].2.11. Statistical analysis
The results were expressed as the means ± SEM of at least 3 exper-
iments performed independently unless stated otherwise. Statistical
analysis was performed by Student-t test. A p-value less than 0.05 de-
noted the presence of a statistically signiﬁcant diﬀerence.3. Results
3.1. The expression of chemerin was strongly induced during
adipocyte diﬀerentiation and secreted into media
Among the 318 genes whose expression levels were changed
during 3T3-L1 adipocyte diﬀerentiation, as detected by diﬀer-
ential display analysis, we found 12 putative secreted mole-
cules, including adiponectin and three unknown signal
sequence containing molecules. One of these three unknown
molecules showed a protein of 164 amino acids with 16 puta-
tive signal peptides (NCBI gene accession No. AK002298),
which was previously reported as TIG2 [7] and Chemerin
[24] (Fig. 1A). Then we performed Northern blot analysis to
validate the results obtained by the diﬀerential display. As
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Fig. 1. Identiﬁcation, expression of TIG2/chemerin in the 3T3-L1
adipocytes: (A) Diﬀerential display for identifying adipocyte diﬀeren-
tiation-related gene in the 3T3-L1 adipocytes. Arrow indicates PCR
fragment equivalent to chemerin. (B) Northern blotting analysis of
chemerin mRNA in the 3T3-L1 and 3T3-F442A adipocytes. Chemerin
mRNA was markedly induced during adipocyte diﬀerentiation both in
the 3T3-L1 and 3T3-F442A adipocytes. (C) Immunoblotting of
chemerin protein in cell culture medium. Cos7 cells were transfected
with chemerin expression vector and the protein in culture media was
detected using ant c-terminal V5 antibody.
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Fig. 2. (A) Tissue distribution of TIG2/chemerin expression in mice.
Fifteen micrograms of total RNA from mice tissue was applied and
analyzed by Northern blotting using mouse chemerin speciﬁc probe.
There was abundant expression in the liver, adipose tissue including
visceral, epididymal, and brown adipose tissue. (B) Semiquantitative
PCR analysis of the expression of chemerin in the liver and epididymal
fat in db/db mice. In the liver, the expression of chemerin was slightly
increased compared to that in control mice. In contrast, the expression
of chemerin was markedly reduced in the epididymal fat. 36B4
expression was used as a control. (C) In db/db mice, the serum
chemerin levels were decreased compared to the control.
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demonstrated that this gene is indeed strongly induced during
adipocyte diﬀerentiation not only in the 3T3-L1 adipocytes but
also in the 3T3-F442A adipocytes, indicating its common
expression pattern in adipocyte diﬀerentiation. Next, we
cloned full-length cDNA using total RNA derived from the
3T3-L1 adipocytes, inserted into an expression vector,
expressed in Cos7 cells, and performed immunoblotting
analysis using cell culture media. Immunobloting analysis
using c-terminal V5 tag clearly showed that this molecule
was secreted into the culture media in a predicted size. This
molecule was initially reported as Tazarotene-induced gene 2
(TIG2) [7] and later identiﬁed as a ligand for the orphan G
protein coupled receptor ChemR23 [8] and was named
chemerin because of its chemoattractant activity to immature
dendrite cells and macrophages [8].
3.2. The expression of chemerin was diﬀerently regulated in liver
and adipose tissue
We next evaluated chemerin gene expression in the mouse. It
has been reported that abundant chemerin transcripts were
found in the liver, lung, pituitary, and ovary [8], however, in
addition to these tissues, Northern blotting analysis clearlyshowed a substantial expression in the adipose tissue including
visceral, epididymal, and brown adipose tissue (Fig. 2A). The
abundant expression in the adipose tissue in vivo supported the
characteristics of chemerin as an adipokine. The expression of
many adipokines is regulated in the changes of metabolic sta-
tus, such as obesity and diabetes. Thus, we analyzed the
changes in the expression of chemerin in the liver and adipose
tissue (Fig. 2B) in db/db mice that show marked obesity and
diabetes because of the lack of leptin receptor. Interestingly,
in the liver, the expression of chemerin was not changed, how-
ever, in epididymal fat, the expression of chemerin was mark-
edly reduced. These results indicated that the expression of
chemerin was diﬀerentially regulated depending on each tissue.
To investigate the physiological function, we generated recom-
binant human chemerin that shares 65% amino acid identity to
the mouse orthologue. Also chemerin-speciﬁc antibody was
raised in rabbit using bacteria-derived human recombinant
chemerin as an antigen. As shown in Fig. 3A, we successfully
576 M. Takahashi et al. / FEBS Letters 582 (2008) 573–578generated and puriﬁed recombinant human chemerin (left pa-
nel) and the antibody speciﬁcally recognized the protein in
immunoblotting analysis (right panel) in the predicted size.
Using this chemerin-speciﬁc antibody, we analyzed the serum
levels of chemerin in the control and db/db mice. Intriguingly,
The serum levels of chemerin were substantially decreased in
diabetic db/db mice (Fig. 2C), suggesting that serum chemerin
levels are associated with obesity and diabetic status.
3.3. Endogenous chemerin was secreted from the 3T3-L1
adipocytes
Using this chemerin-speciﬁc antibody, we conducted
immunoblotting analysis to clarify if the endogenous chemerin
is secreted into the supernatant of 3T3-L1 adipocytes culture
media. It has been reported that chemerin was secereted into
media as 18 kDa prochemerin and processed enzymatically
to be activated as chemerin that was truncated in its c-termi-
nals. As shown in Fig. 3B, after adipocyte diﬀerentiation,
chemerin was secreted into the culture media of the 3T3-L1
adipocytes in a predicted size of cleaved active form.Fig. 3. (A) Generation of recombinant human chemerin and speciﬁc antibod
in a soluble form. Puriﬁed 3 or 5 lg of recombinant human chemerin in each
(left panel). Immunoblotting analysis using the antibody raised by recombina
Endogenous chemerin was present in the culture media in the diﬀerentiated
positive control. A presence of the bands corresponding to the high molecu
expressed during adipocyte diﬀerentiation. ChemR23 was also expressed inGenerally, adipokines exert its eﬀect not only in endocrine
manner as a hormone but also in autocrine/paracrine manner
in adipose tissue. We analyzed the protein expression pattern
of chemerin and its receptor/ChemR23 using immunohisto-
chemistry. The chemerin-speciﬁc antibody recognized the pro-
tein expression in the diﬀerentiated 3T3-L1 adipocytes
(Fig. 3C). The immunohitochemical analysis demonstrated
that ChemR23 was expressed in the diﬀerentiated 3T3-L1 adi-
pocytes as well as the ligand. These results imply that chemerin
exerts its biological action in autocrine/paracrine manner in
the adipocytes.
3.4. Chemerin potentiated insulin-stimulated glucose uptake in
3T3-L1 adipocytes
The fact that 3T3-L1 cells secrete chemerin and its receptor
is expressed in the 3T3-L1 adipocytes suggested that this factor
might modulate adipocyte function such as insulin-stimulated
glucose transport through autocrine/paracrine mechanism. We
incubated the 3T3-L1 adipocytes with recombinant human
chemerin and measured the uptake of 2-deoxyglucose in they. Recombinant human chemerin was generated in baculovirus system
lane was applied to SDS–PAGE and visualized by Coomassie-staining
nt human chemerin speciﬁcally recognized the protein (right panel). (B)
3T3-L1 adipocytes. Recombinant human chemerin was applied as a
lar weight suggests that chemerin forms multimer. (C) Chemerin was
the mature adipocytes.
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incubation with 100 ng/ml recombinant human chemerin
signiﬁcantly potentiated insulin-stimulated glucose uptake by
41% (Fig. 4A). Similar results were obtained using commer-
cially available recombinant mouse chemerin (data not
shown). In addition, inubation with chemerin potentiated
insulin-stimulated tyrosine phosphorylation of IRS-1
(Fig. 4B). These results clearly demonstrated that chemerin
regulates insulin sensitivity in the 3T3L1 adipocytes in
autocrine/paracrine manner.4. Discussion
To explore a novel adipokine, we screened adipocyte diﬀer-
entiation-related gene using diﬀerential display and found that
chemerin is strongly induced during the adipocyte diﬀerentia-
tion. We also demonstrated that chemerin was secreted during
adipocyte diﬀerentiation in vitro and was expressed abun-
dantly in adipose tissue in vivo. Chemerin and its receptor/
ChemR23 were expressed during the adipocyte diﬀerentiation,
suggesting that chemerin exerted in autocrine/paracrine
fashion. These data were compatible with the recent report
[11–13]; however we further show the functional and physio-
logical relevance of this novel adipokine chemerin. Intrigu-
ingly, the expression of chemerin in vivo was diﬀerently
regulated in the liver and adipose tissue in db/db mice. We fur-
ther demonstrated that the serum chemerin concentration was
decreased in db/db mice. In addition, chemerin potentiated
insulin-stimulated glucose uptake in the 3T3-L1 adipocytes
concomitant with enhancing insulin signaling. These data sug-
gest pathophysiological signiﬁcance of chemerin in obesity and
diabetes. It is also demonstrated that chemerin is a novel
adipokine that regulates insulin sensitivity in adipose tissue.Bozaoglu et al. demonstrated that the expression of chemer-
in in adipose tissue of obese and type 2 diabetic Psammomys
obesus was signiﬁcantly higher than that in lean, normoglyce-
mic P. obesus [12]. In contrast, we found that the expression
of chemerin in epididymal fat was markedly reduced in db/db
mice. Although the precise reason of this discrepancy is
unclear, this could be due to the species diﬀerence. We further
demonstrated that the serum chemerin concentration was
substantially reduced concomitant with the reduction in the
expression in the adipose tissue, suggesting that the adipose
tissue is a main source of serum chemerin.
ChemR23 also known as Dez in mice was an orphan G pro-
tein-coupled receptor related to chemokine receptor expressed
in macrophages and immature DCs [25]. Chemerin was origi-
nally reported as a tazarotene-induced gene in skin raft with
unknown function [7] and has recently been reported as a
ligand for ChemR23 and was abundantly present in human
inﬂammatory ﬂuids [8]. Chemerin was shown to be activated
by proteolytic cleavage and promote calcium mobilization
and chemotaxis of immature DCs and macrophages [8,26].
These data suggested that chemerin plays a potential role in
regulating inﬂammation by recruiting antigen-presenting cells.
However, it has not been elucidated the essential role of chem-
erin especially in metabolic regulation.
Recently, it has been reported that macrophage accumula-
tion and associated chronic inﬂammation in adipose tissue
are related to the pathogenesis of obesity and insulin resistance
[27,28] Emerging evidences indicate that obesity is an inﬂam-
matory disease as well as atherosclerosis [29]. In this aspect,
it is intriguing that this novel adipokine, chemerin regulates
the inﬂammation and macrophage recruitment as well as insu-
lin sensitivity in adipose tissue.
More recently, chemerin has been reported as a adipokine
and regulates adipocyte diﬀerentiation [11], serum chemerin
level was associated with body mass index, circulating tri-
glycerides and blood pressure [12], and chemerin stimulates
ERK1/2 and lipolysis in the 3T3L1 adipocytes [13]. Together
with our data, it is suggested that chemerin is a novel adipo-
kine that regulates adipocyte diﬀerentiation and function and
is related to the pathogenesis of metabolic syndrome.
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